Metraipolis › archive › dc_7d3d22468802

SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation — Europe PMC PMID:42454485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42454485
DOI
10.1172/jci199709
License (as archived)
solo-consultazione
Archived
2026-10-18T06:48:00.316Z
SHA-256 of the archived text
eda4a880ed4de36ec04a858a56b26ea074ec6b5ee77190930091dc716042a7e7
Stable URL of this page
https://metraipolis.com/documento/dc_7d3d22468802

How to cite

SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation — Europe PMC PMID:42454485 — Europe PMC (en), https://europepmc.org/article/MED/42454485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d3d22468802 (Metraipolis archive dc_7d3d22468802, sha256 eda4a880ed4de36ec04a858a56b26ea074ec6b5ee77190930091dc716042a7e7)
BibTeX
@misc{dc7d3d22468802,
  title = {SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation — Europe PMC PMID:42454485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42454485},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d3d22468802; sha256 eda4a880ed4de36ec04a858a56b26ea074ec6b5ee77190930091dc716042a7e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42454485. Agents can read the archived copy with the MCP tool read_document.